Testagen for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Testagen for Health & Longevity

Created on 09/30/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Testagen is a lab-made four-amino-acid peptide promoted to support male hormone output, fertility, and healthy aging. Human evidence is one small study without a placebo, in men treated for prostate inflammation; those adding Testagen showed higher testosterone and fewer prostate symptoms. No study has measured sperm or aging. No side effects have been recorded, but no one has systematically looked; product quality is the most concrete concern. (Full Review)

Protocol

Oral developer course
2 capsules once or twice daily
Before meals for 1 month, repeated after 3–6 months; per the developer-linked manufacturer. No dose-finding study exists.
Clinically tested regimen
2 capsules twice daily
With meals for 30 days alongside prostatitis treatment; 0.1 mg of peptide per capsule
Injectable vial course
1–2 mg subcutaneously daily
For 10–20 days, 1–3 courses yearly; vendor convention, not from any study or named clinic
Time to effect
Testosterone
After one month
Reported in the one human study, which measured no time course
Prostate symptoms and urine flow
After one month
Same trial; standard therapy alone also improved them
Energy or libido
2–4 weeks (vendor claim)
Time to effect unknown; no study has measured libido

Benefits

Contraindications
  • Men with active or treated prostate cancer, or PSA above 4.0 ng/mL (or rising more than 0.75 ng/mL per year) until evaluated
  • Any active cancer or cancer treatment within the past 5 years
  • Pregnant or breastfeeding women
  • People under 18 years of age
  • Organ-transplant recipients on immunosuppressants
  • Uncontrolled thyroid disease (TSH outside 0.4–4.5 mIU/L)
  • Severe kidney impairment (eGFR below 30 mL/min/1.73 m²)
  • Competitive athletes subject to anti-doping testing
    •
Key Interactions
  • Testosterone-raising drugs (testosterone, hCG, clomiphene): caution
  • Thyroid medications (levothyroxine, liothyronine, methimazole): monitor
  • Immunosuppressants (tacrolimus, cyclosporine, mycophenolate): caution
  • Anticoagulants (warfarin, apixaban, rivaroxaban): monitor
  • Over-the-counter medications (aspirin, ibuprofen, naproxen): monitor
  • Testosterone-supporting supplements (DHEA, tongkat ali, zinc, fenugreek): caution
  • Other peptide bioregulators (Testoluten, Epitalon, Thymalin, Prostamax): caution
  • No interaction documented in any study; all theoretical
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Substandard or contaminated product
    •
  • Speculative: Thyroid hormone shifts; immune-system changes; clotting changes; stimulation of hormone-sensitive or abnormal tissue; injection-site reactions and infection; delayed diagnosis of treatable causes
    •

Monitoring

Marker Target Why
Total testosterone 600–900 ng/dL Main claimed target
Free testosterone About 135–225 pg/mL Active hormone fraction
LH 2–8 IU/L Shows whether pituitary drive changes
FSH 1.5–8 IU/L Marker of sperm-production drive
SHBG 20–50 nmol/L Affects free testosterone
Estradiol 20–30 pg/mL Estrogen balance in men
TSH 0.5–2.5 mIU/L Detects thyroid-axis shifts seen in birds
Free T4 1.0–1.5 ng/dL Confirms thyroid output
PSA Below 1.0 ng/mL, stable over time Prostate safety
Semen analysis Concentration ≥ 16 million/mL, progressive motility ≥ 30% Direct fertility outcome (when fertility is the goal)
CBC Hemoglobin 14–16 g/dL; normal white cells and platelets General safety
CMP ALT below 25 U/L; eGFR above 90 mL/min/1.73 m² Liver and kidney safety

Cadence: Baseline before a first course (morning, fasting); hormone and thyroid panel 4–6 weeks after starting, at the end of each course, then every 6–12 months while courses continue; PSA after each course in men over 45; blood count and chemistry annually; semen analysis repeated after about 74 days.

Qualitative Assessment

  • Morning erections and libido
  • Energy and exercise recovery
  • Mood, motivation, and irritability
  • Sleep quality
  • Injection-site redness, swelling, or pain
  • Palpitations, heat intolerance, or weight change (possible thyroid shifts)
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.